Rare diseases
Investigational molecules
Locations
Evaluation of CIT-013 at two dose levels compared to placebo for treating moderate to severe Hidradenitis Suppurativa
GermanyStudy of navenibart to prevent attacks in adults and adolescents with Hereditary Angioedema
AustriaStudy of IncobotulinumtoxinA injections compared to placebo for prevention of episodic migraine attacks
AustriaStudy of incobotulinumtoxinA injections for prevention of chronic migraine in adult patients
AustriaComparison of zasocitinib and deucravacitinib in adults with moderate to severe plaque psoriasis
BulgariaStudy of IPN10200 compared to placebo for prevention of episodic or chronic migraine in adults
CzechiaStudy of zasocitinib (TAK-279) and apremilast compared to placebo in adults with moderate to severe plaque psoriasis
BulgariaStudy of TAK-279 and apremilast for adults with moderate to severe plaque psoriasis
GermanyStudy of SAR441566 and methotrexate in adults with moderate to severe rheumatoid arthritis
CzechiaStudy of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis
AustriaStudy of rocatinlimab (AMG 451) in adolescents with moderate to severe atopic dermatitis to evaluate its effectiveness and safety over 52 weeks
BelgiumStudy of Verekitug to improve symptoms in patients with moderate to severe chronic obstructive pulmonary disease (COPD)
BulgariaTell us about your condition – we search every trial in Europe and connect you with the right site.
